JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 18, 2005; DOI: 10.1124/jpet.105.083634


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.083634v1
314/1/9    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linder, A. E.
Right arrow Articles by Webb, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linder, A. E.
Right arrow Articles by Webb, R. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE


Received for publication January 13, 2005.
Revised March 16, 2005.
Accepted for publication March 17, 2005.

DYNAMIC ASSOCIATION OF NITRIC OXIDE DOWNSTREAM SIGNALING MOLECULES WITH ENDOTHELIAL CAVEOLIN-1 IN RAT AORTA

Aurea Elizabeth Linder 1*, Lynnette P. McCluskey 1, Kenneth R. Cole III 1, Katherine M. Lanning 1, R. Clinton Webb 1

1 Medical College of Georgia

* Address correspondence to: E-mail: elinder{at}mcg.edu

Abstract

Classically, nitric oxide (NO) formed by endothelial NO synthase (eNOS) freely diffuses from its generation site to smooth muscle cells where it activates soluble guanylyl cyclase (sGC) producing guanosine 3'5'cyclic monophosphate (cGMP). Subsequently, cGMP activates both cGMP- and adenosine 3'5'cyclic monophosphate (cAMP)-dependent protein kinases (PKG and PKA, respectively) leading to smooth muscle relaxation. In endothelial cells, eNOS has been localized to caveolae, small invaginations of the plasma membrane rich in cholesterol. Membrane cholesterol depletion impairs acetylcholine (Ach)-induced relaxation due to alteration in caveolar structure. Given the nature of NO to be more soluble in a hydrophobic environment than in water, and assuming that co-localization of components in a signal transdution cascade appears to be a critical determinant of signaling efficiency by eNOS activation, we hypothesize that sGC, PKA and PKG activation may occur at the plasma membrane caveolae. In endothelium-intact rat aortic rings, the relaxation induced by ACh-, by the sGC activator 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1) and by 8-Bromoguanosine 3': 5'-cyclic monophosphate (8-Br-cGMP) was impaired in the presence of methyl-{beta}-cyclodextrin, a drug that disassembles caveolae by sequestering cholesterol from the membrane. sGC, PKG and PKA were co-localized with caveolin-1 in aortic endothelium and this co-localization was abolished by methyl-{beta}-cyclodextrin. Methyl-{beta}-cyclodextrin efficiently disassembled caveolae in endothelium. In summary, our results provide evidence of compartmentalization of sGC, PKG and PKA in endothelial caveolae contributing to NO signaling cascade giving new insights by which the endothelium mediates vascular smooth muscle relaxation.


Key words: cAMP-dependent protein kinase, cGMP, caveolin-1, endothelium, smooth muscle, vasodilation


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Miersch, M. G. Espey, R. Chaube, A. Akarca, R. Tweten, S. Ananvoranich, and B. Mutus
Plasma Membrane Cholesterol Content Affects Nitric Oxide Diffusion Dynamics and Signaling
J. Biol. Chem., July 4, 2008; 283(27): 18513 - 18521.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. J. Rodrigues, C. B. Restini, C. N. Lunardi, J. E. Moreira, R. G. Lima, R. S. da Silva, and L. M. Bendhack
Caveolae Dysfunction Contributes to Impaired Relaxation Induced by Nitric Oxide Donor in Aorta from Renal Hypertensive Rats
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, K. M. Thakali, J. M. Thompson, S. W. Watts, R. C. Webb, and R. Leite
Methyl-beta-cyclodextrin Prevents Angiotensin II-Induced Tachyphylactic Contractile Responses in Rat Aorta
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 78 - 84.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Z. Valic, I. Palada, and Z. Dujic
Short-acting NO donor and decompression sickness in humans
J Appl Physiol, April 1, 2007; 102(4): 1725 - 1725.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H. Zhang and S. A. Fisher
Conditioning Effect of Blood Flow on Resistance Artery Smooth Muscle Myosin Phosphatase
Circ. Res., March 16, 2007; 100(5): 730 - 737.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
L. A. Piggott, K. A. Hassell, Z. Berkova, A. P. Morris, M. Silberbach, and T. C. Rich
Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments
J. Gen. Physiol., June 26, 2006; 128(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. E. Linder, R. Leite, K. Lauria, T. M. Mills, and R. C. Webb
Penile erection requires association of soluble guanylyl cyclase with endothelial caveolin-1 in rat corpus cavernosum
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1302 - R1308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. L. Dodge-Kafka, L. Langeberg, and J. D. Scott
Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of A-Kinase Anchoring Proteins
Circ. Res., April 28, 2006; 98(8): 993 - 1001.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.